Anastasios Aslidis - 31 Dec 2024 Form 5 Insider Report for Cosmos Health Inc. (COSM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
5
Accepted by SEC
14 Feb 2025, 17:18:40 UTC
Prior SEC filing
22 Dec 2023
Next SEC filing
11 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anastasios Aslidis

Key filing fact

Anastasios Aslidis filed Form 5 for Cosmos Health Inc. (COSM) on 14 Feb 2025.

Key facts

  • This page summarizes Anastasios Aslidis's Form 5 filing for Cosmos Health Inc. (COSM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Feb 2025, 17:18.

Change

  • Previous filing in this sequence was filed on 22 Dec 2023.
  • Current net transaction value: +$20.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

COSM transaction

Common Stock, par value $.001

Award

Transaction value
$20
Shares
+20,000
Change %
+100%
Price
$0.001000
Shares after
40,000
Date
19 Sep 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On September 19, 2024, Anastasios Aslidis received 20,000 incentive shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .